 | • レポートコード：C-GIR20G3085 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「心臓弁膜症治療の世界市場2019年」は、グローバルにおける心臓弁膜症治療市場を展望するレポートです。心臓弁膜症治療のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・心臓弁膜症治療の市場概観 ・心臓弁膜症治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・心臓弁膜症治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・心臓弁膜症治療の世界市場規模 ・心臓弁膜症治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・心臓弁膜症治療のアメリカ市場規模推移 ・心臓弁膜症治療のカナダ市場規模推移 ・心臓弁膜症治療のメキシコ市場規模推移 ・心臓弁膜症治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・心臓弁膜症治療のドイツ市場規模推移 ・心臓弁膜症治療のイギリス市場規模推移 ・心臓弁膜症治療のロシア市場規模推移 ・心臓弁膜症治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・心臓弁膜症治療の日本市場規模推移 ・心臓弁膜症治療の中国市場規模推移 ・心臓弁膜症治療の韓国市場規模推移 ・心臓弁膜症治療のインド市場規模推移 ・心臓弁膜症治療の東南アジア市場規模推移 ・心臓弁膜症治療の南米市場分析（ブラジル、アルゼンチン等） ・心臓弁膜症治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・心臓弁膜症治療の種類別分析/販売量、売上、市場シェア（心臓カテーテル法、心電図（ECG）、胸部X線、ストレステスト、その他） ・心臓弁膜症治療の用途別分析/市場規模（病院および診療所、外来手術センター、研究所） ・心臓弁膜症治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・心臓弁膜症治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Valvular Heart Disease Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Valvular Heart Disease Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Valvular Heart Disease Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Valvular Heart Disease Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
LivaNova PLC
Neovasc Inc.
Medtronic
B. Braun Melsungen AG
Abbott Laboratories
Boston Scientific Corp.
Symetis SA
Edwards Lifesciences Corporation
CryoLife Inc.
Micro Interventional Devices
Braile Biomédica
Jenavalve Technology
Lepu Medical Technology Co.
TTK Healthcare Limited
Colibri Heart Valve
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Cardiac Catheterization
Electrocardiogram (ECG)
Chest X-Ray
Stress Test
Others
Market Segment by Applications, can be divided into
Hospital & Clinics
Ambulatory Surgical Centers
Research Institutes
Table of Contents
1 Valvular Heart Disease Treatment Market Overview
1.1 Product Overview and Scope of Valvular Heart Disease Treatment
1.2 Classification of Valvular Heart Disease Treatment by Types
1.2.1 Global Valvular Heart Disease Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Valvular Heart Disease Treatment Revenue Market Share by Types in 2018
1.2.3 Cardiac Catheterization
1.2.4 Electrocardiogram (ECG)
1.2.5 Chest X-Ray
1.2.6 Stress Test
1.2.7 Others
1.3 Global Valvular Heart Disease Treatment Market by Application
1.3.1 Global Valvular Heart Disease Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital & Clinics
1.3.3 Ambulatory Surgical Centers
1.3.4 Research Institutes
1.4 Global Valvular Heart Disease Treatment Market by Regions
1.4.1 Global Valvular Heart Disease Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Valvular Heart Disease Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Valvular Heart Disease Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Valvular Heart Disease Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Valvular Heart Disease Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Valvular Heart Disease Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Valvular Heart Disease Treatment (2014-2024)
2 Company Profiles
2.1 LivaNova PLC
2.1.1 Business Overview
2.1.2 Valvular Heart Disease Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 LivaNova PLC Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Neovasc Inc.
2.2.1 Business Overview
2.2.2 Valvular Heart Disease Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Neovasc Inc. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Medtronic
2.3.1 Business Overview
2.3.2 Valvular Heart Disease Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Medtronic Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 B. Braun Melsungen AG
2.4.1 Business Overview
2.4.2 Valvular Heart Disease Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 B. Braun Melsungen AG Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Abbott Laboratories
2.5.1 Business Overview
2.5.2 Valvular Heart Disease Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Abbott Laboratories Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Boston Scientific Corp.
2.6.1 Business Overview
2.6.2 Valvular Heart Disease Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Boston Scientific Corp. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Symetis SA
2.7.1 Business Overview
2.7.2 Valvular Heart Disease Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Symetis SA Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Edwards Lifesciences Corporation
2.8.1 Business Overview
2.8.2 Valvular Heart Disease Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Edwards Lifesciences Corporation Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 CryoLife Inc.
2.9.1 Business Overview
2.9.2 Valvular Heart Disease Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 CryoLife Inc. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 Micro Interventional Devices
2.10.1 Business Overview
2.10.2 Valvular Heart Disease Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Micro Interventional Devices Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.11 Braile Biomédica
2.11.1 Business Overview
2.11.2 Valvular Heart Disease Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Braile Biomédica Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.12 Jenavalve Technology
2.12.1 Business Overview
2.12.2 Valvular Heart Disease Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Jenavalve Technology Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.13 Lepu Medical Technology Co.
2.13.1 Business Overview
2.13.2 Valvular Heart Disease Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Lepu Medical Technology Co. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.14 TTK Healthcare Limited
2.14.1 Business Overview
2.14.2 Valvular Heart Disease Treatment Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 TTK Healthcare Limited Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.15 Colibri Heart Valve
2.15.1 Business Overview
2.15.2 Valvular Heart Disease Treatment Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Colibri Heart Valve Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Valvular Heart Disease Treatment Market Competition, by Players
3.1 Global Valvular Heart Disease Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Valvular Heart Disease Treatment Players Market Share
3.2.2 Top 10 Valvular Heart Disease Treatment Players Market Share
3.3 Market Competition Trend
4 Global Valvular Heart Disease Treatment Market Size by Regions
4.1 Global Valvular Heart Disease Treatment Revenue and Market Share by Regions
4.2 North America Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
5 North America Valvular Heart Disease Treatment Revenue by Countries
5.1 North America Valvular Heart Disease Treatment Revenue by Countries (2014-2019)
5.2 USA Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
6 Europe Valvular Heart Disease Treatment Revenue by Countries
6.1 Europe Valvular Heart Disease Treatment Revenue by Countries (2014-2019)
6.2 Germany Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
6.4 France Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Valvular Heart Disease Treatment Revenue by Countries
7.1 Asia-Pacific Valvular Heart Disease Treatment Revenue by Countries (2014-2019)
7.2 China Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
7.5 India Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
8 South America Valvular Heart Disease Treatment Revenue by Countries
8.1 South America Valvular Heart Disease Treatment Revenue by Countries (2014-2019)
8.2 Brazil Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Valvular Heart Disease Treatment by Countries
9.1 Middle East and Africa Valvular Heart Disease Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
10 Global Valvular Heart Disease Treatment Market Segment by Type
10.1 Global Valvular Heart Disease Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Valvular Heart Disease Treatment Market Forecast by Type (2019-2024)
10.3 Cardiac Catheterization Revenue Growth Rate (2014-2024)
10.4 Electrocardiogram (ECG) Revenue Growth Rate (2014-2024)
10.5 Chest X-Ray Revenue Growth Rate (2014-2024)
10.6 Stress Test Revenue Growth Rate (2014-2024)
10.7 Others Revenue Growth Rate (2014-2024)
11 Global Valvular Heart Disease Treatment Market Segment by Application
11.1 Global Valvular Heart Disease Treatment Revenue Market Share by Application (2014-2019)
11.2 Valvular Heart Disease Treatment Market Forecast by Application (2019-2024)
11.3 Hospital & Clinics Revenue Growth (2014-2019)
11.4 Ambulatory Surgical Centers Revenue Growth (2014-2019)
11.5 Research Institutes Revenue Growth (2014-2019)
12 Global Valvular Heart Disease Treatment Market Size Forecast (2019-2024)
12.1 Global Valvular Heart Disease Treatment Market Size Forecast (2019-2024)
12.2 Global Valvular Heart Disease Treatment Market Forecast by Regions (2019-2024)
12.3 North America Valvular Heart Disease Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Valvular Heart Disease Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Valvular Heart Disease Treatment Revenue Market Forecast (2019-2024)
12.6 South America Valvular Heart Disease Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Valvular Heart Disease Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Valvular Heart Disease Treatment Picture
Table Product Specifications of Valvular Heart Disease Treatment
Table Global Valvular Heart Disease Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Valvular Heart Disease Treatment Revenue Market Share by Types in 2018
Figure Cardiac Catheterization Picture
Figure Electrocardiogram (ECG) Picture
Figure Chest X-Ray Picture
Figure Stress Test Picture
Figure Others Picture
Table Global Valvular Heart Disease Treatment Revenue (Million USD) by Application (2014-2024)
Figure Valvular Heart Disease Treatment Revenue Market Share by Applications in 2018
Figure Hospital & Clinics Picture
Figure Ambulatory Surgical Centers Picture
Figure Research Institutes Picture
Table Global Market Valvular Heart Disease Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Valvular Heart Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Valvular Heart Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Valvular Heart Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Valvular Heart Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Valvular Heart Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Valvular Heart Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table LivaNova PLC Basic Information, Manufacturing Base and Competitors
Table LivaNova PLC Valvular Heart Disease Treatment Type and Applications
Table LivaNova PLC Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Neovasc Inc. Basic Information, Manufacturing Base and Competitors
Table Neovasc Inc. Valvular Heart Disease Treatment Type and Applications
Table Neovasc Inc. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Medtronic Basic Information, Manufacturing Base and Competitors
Table Medtronic Valvular Heart Disease Treatment Type and Applications
Table Medtronic Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table B. Braun Melsungen AG Basic Information, Manufacturing Base and Competitors
Table B. Braun Melsungen AG Valvular Heart Disease Treatment Type and Applications
Table B. Braun Melsungen AG Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Valvular Heart Disease Treatment Type and Applications
Table Abbott Laboratories Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Boston Scientific Corp. Basic Information, Manufacturing Base and Competitors
Table Boston Scientific Corp. Valvular Heart Disease Treatment Type and Applications
Table Boston Scientific Corp. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Symetis SA Basic Information, Manufacturing Base and Competitors
Table Symetis SA Valvular Heart Disease Treatment Type and Applications
Table Symetis SA Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Edwards Lifesciences Corporation Basic Information, Manufacturing Base and Competitors
Table Edwards Lifesciences Corporation Valvular Heart Disease Treatment Type and Applications
Table Edwards Lifesciences Corporation Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table CryoLife Inc. Basic Information, Manufacturing Base and Competitors
Table CryoLife Inc. Valvular Heart Disease Treatment Type and Applications
Table CryoLife Inc. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Micro Interventional Devices Basic Information, Manufacturing Base and Competitors
Table Micro Interventional Devices Valvular Heart Disease Treatment Type and Applications
Table Micro Interventional Devices Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Braile Biomédica Basic Information, Manufacturing Base and Competitors
Table Braile Biomédica Valvular Heart Disease Treatment Type and Applications
Table Braile Biomédica Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Jenavalve Technology Basic Information, Manufacturing Base and Competitors
Table Jenavalve Technology Valvular Heart Disease Treatment Type and Applications
Table Jenavalve Technology Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Lepu Medical Technology Co. Basic Information, Manufacturing Base and Competitors
Table Lepu Medical Technology Co. Valvular Heart Disease Treatment Type and Applications
Table Lepu Medical Technology Co. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table TTK Healthcare Limited Basic Information, Manufacturing Base and Competitors
Table TTK Healthcare Limited Valvular Heart Disease Treatment Type and Applications
Table TTK Healthcare Limited Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Colibri Heart Valve Basic Information, Manufacturing Base and Competitors
Table Colibri Heart Valve Valvular Heart Disease Treatment Type and Applications
Table Colibri Heart Valve Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Valvular Heart Disease Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Valvular Heart Disease Treatment Revenue Share by Players (2014-2019)
Figure Global Valvular Heart Disease Treatment Revenue Share by Players in 2017
Figure Global Valvular Heart Disease Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Valvular Heart Disease Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Valvular Heart Disease Treatment Revenue Market Share in 2018
Figure Global Valvular Heart Disease Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Valvular Heart Disease Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Valvular Heart Disease Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Valvular Heart Disease Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Valvular Heart Disease Treatment Revenue Market Share by Regions in 2018
Figure North America Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure South America Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Table North America Valvular Heart Disease Treatment Revenue by Countries (2014-2019)
Table North America Valvular Heart Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Valvular Heart Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Valvular Heart Disease Treatment Revenue Market Share by Countries in 2018
Figure USA Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Table Europe Valvular Heart Disease Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Valvular Heart Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Valvular Heart Disease Treatment Revenue Market Share by Countries in 2018
Figure Germany Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure UK Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure France Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Valvular Heart Disease Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Valvular Heart Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Valvular Heart Disease Treatment Revenue Market Share by Countries in 2018
Figure China Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure India Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Table South America Valvular Heart Disease Treatment Revenue by Countries (2014-2019)
Table South America Valvular Heart Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Valvular Heart Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Valvular Heart Disease Treatment Revenue Market Share by Countries in 2018
Figure Brazil Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Valvular Heart Disease Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Valvular Heart Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Valvular Heart Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Valvular Heart Disease Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Table Global Valvular Heart Disease Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Valvular Heart Disease Treatment Revenue Share by Type (2014-2019)
Figure Global Valvular Heart Disease Treatment Revenue Share by Type (2014-2019)
Figure Global Valvular Heart Disease Treatment Revenue Share by Type in 2018
Table Global Valvular Heart Disease Treatment Revenue Forecast by Type (2019-2024)
Figure Global Valvular Heart Disease Treatment Market Share Forecast by Type (2019-2024)
Figure Global Cardiac Catheterization Revenue Growth Rate (2014-2019)
Figure Global Electrocardiogram (ECG) Revenue Growth Rate (2014-2019)
Figure Global Chest X-Ray Revenue Growth Rate (2014-2019)
Figure Global Stress Test Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Valvular Heart Disease Treatment Revenue by Application (2014-2019)
Table Global Valvular Heart Disease Treatment Revenue Share by Application (2014-2019)
Figure Global Valvular Heart Disease Treatment Revenue Share by Application (2014-2019)
Figure Global Valvular Heart Disease Treatment Revenue Share by Application in 2018
Table Global Valvular Heart Disease Treatment Revenue Forecast by Application (2019-2024)
Figure Global Valvular Heart Disease Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospital & Clinics Revenue Growth Rate (2014-2019)
Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2014-2019)
Figure Global Research Institutes Revenue Growth Rate (2014-2019)
Figure Global Valvular Heart Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Valvular Heart Disease Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Valvular Heart Disease Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Valvular Heart Disease Treatment Revenue Market Forecast (2019-2024)
Figure Europe Valvular Heart Disease Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Valvular Heart Disease Treatment Revenue Market Forecast (2019-2024)
Figure South America Valvular Heart Disease Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Valvular Heart Disease Treatment Revenue Market Forecast (2019-2024)
先天性心疾患市場：世界及び中国市場分析・予測（～2024年） Congenital Heart Disease Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Congenital Heart Disease industry with a focus on the Chinese market. The report provides key statistics on the market status of the Congenital Heart Dis…- 世界のレフサム病治療市場予測（～2024年） Refsum disease, also known as classic or adult Refsum disease, heredopathia atactica polyneuritiformis, phytanic acid oxidase deficiency and phytanic acid storage disease, is an autosomal recessive neurological disease that results in the over-accumulation of phytanic acid in cells and tissues. Scop…
- 世界のアジソン病治療市場予測（～2024年） Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Symptoms generally come on slowly and may include abdominal pain, weakness, and weight loss. Darkening of the skin…
- 世界のバッテン病治療市場予測（～2024年） Batten disease is inherited disorder of the nervous system which begins in childhood.It is also called as neuronal ceroid lipofuscinoses (or NCLs). Batten Disease Treatment is the treatment of this type of disease. Scope of the Report: The global Batten Disease Treatment market is valued at xx milli…
- パジェット病治療の世界市場 2019年版：種類別（ビスホスホネート、カルシトニン類似体（サーモンカルシトニン）、鎮痛剤、カルシウムおよびビタミンDサプリメント）、用途別（病院、診療所、その他） Scope of the Report: The global Paget's Disease Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China,…